Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain

Abstract Background Chest pain is a serious symptom that is routinely investigated as a sign of coronary artery disease. Non-cardiac chest pain (NCCP) is indistinguishable from ischemic chest pain and both are considered serious and receive similar medical investigations. Although NCCP is not associ...

Full description

Bibliographic Details
Main Authors: Mohammad J. Alkhatatbeh, Noor A. Amara, Khalid K. Abdul-Razzak
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-019-0961-3
id doaj-ccf69ce2775d4672b8f66da430e40352
record_format Article
spelling doaj-ccf69ce2775d4672b8f66da430e403522020-11-25T01:30:45ZengBMCLipids in Health and Disease1476-511X2019-01-0118111010.1186/s12944-019-0961-3Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest painMohammad J. Alkhatatbeh0Noor A. Amara1Khalid K. Abdul-Razzak2Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and TechnologyDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and TechnologyDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and TechnologyAbstract Background Chest pain is a serious symptom that is routinely investigated as a sign of coronary artery disease. Non-cardiac chest pain (NCCP) is indistinguishable from ischemic chest pain and both are considered serious and receive similar medical investigations. Although NCCP is not associated with cardiovascular diseases (CVDs), patients with NCCP may become anxious and frightened from developing coronary events. So, it will be valuable to improve modifiable cardiovascular risk factors in such subjects to reduce fear from CVDs. Because vitamin D deficiency was considered as a possible modifiable cardiovascular risk factor, our aim was to investigate association between serum vitamin D and cardiovascular risk variables in subjects with NCCP. Methods A cross-sectional study involved 104 subjects who underwent cardiac catheterization that did not reveal any cardiac origin for their chest pain. 25-hydroxyvitamin D was measured by electrochemiluminescence immunoassay, glucose was measured by hexokinase method, hemoglobin A1c (HbA1c) was measured by turbidimetric inhibition immunoassay and lipid profile was measured by enzymatic colorimetric assays. Results High density lipoprotein cholesterol (HDL-C) was significantly higher in subjects with sufficient vitamin D compared to those with insufficient or deficient vitamin D (p-value< 0.01). 25-hydroxyvitamin D was positively associated with HDL-C (p-value< 0.01) and inversely associated with HbA1c (p-value = 0.02). 25-hydroxyvitamin D was not significantly correlated with other cardiovascular biomarkers including blood pressure, glucose, and other components of lipid profile (p-values> 0.05). Conclusions low serum vitamin D could be involved in reducing HDL-C and increasing HbA1c and thus it may increase cardiovascular risk in subjects with NCCP.http://link.springer.com/article/10.1186/s12944-019-0961-3Cardiovascular riskVitamin DHigh density lipoproteinHbA1cNon-cardiac chest pain
collection DOAJ
language English
format Article
sources DOAJ
author Mohammad J. Alkhatatbeh
Noor A. Amara
Khalid K. Abdul-Razzak
spellingShingle Mohammad J. Alkhatatbeh
Noor A. Amara
Khalid K. Abdul-Razzak
Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain
Lipids in Health and Disease
Cardiovascular risk
Vitamin D
High density lipoprotein
HbA1c
Non-cardiac chest pain
author_facet Mohammad J. Alkhatatbeh
Noor A. Amara
Khalid K. Abdul-Razzak
author_sort Mohammad J. Alkhatatbeh
title Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain
title_short Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain
title_full Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain
title_fullStr Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain
title_full_unstemmed Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain
title_sort association of 25-hydroxyvitamin d with hdl-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain
publisher BMC
series Lipids in Health and Disease
issn 1476-511X
publishDate 2019-01-01
description Abstract Background Chest pain is a serious symptom that is routinely investigated as a sign of coronary artery disease. Non-cardiac chest pain (NCCP) is indistinguishable from ischemic chest pain and both are considered serious and receive similar medical investigations. Although NCCP is not associated with cardiovascular diseases (CVDs), patients with NCCP may become anxious and frightened from developing coronary events. So, it will be valuable to improve modifiable cardiovascular risk factors in such subjects to reduce fear from CVDs. Because vitamin D deficiency was considered as a possible modifiable cardiovascular risk factor, our aim was to investigate association between serum vitamin D and cardiovascular risk variables in subjects with NCCP. Methods A cross-sectional study involved 104 subjects who underwent cardiac catheterization that did not reveal any cardiac origin for their chest pain. 25-hydroxyvitamin D was measured by electrochemiluminescence immunoassay, glucose was measured by hexokinase method, hemoglobin A1c (HbA1c) was measured by turbidimetric inhibition immunoassay and lipid profile was measured by enzymatic colorimetric assays. Results High density lipoprotein cholesterol (HDL-C) was significantly higher in subjects with sufficient vitamin D compared to those with insufficient or deficient vitamin D (p-value< 0.01). 25-hydroxyvitamin D was positively associated with HDL-C (p-value< 0.01) and inversely associated with HbA1c (p-value = 0.02). 25-hydroxyvitamin D was not significantly correlated with other cardiovascular biomarkers including blood pressure, glucose, and other components of lipid profile (p-values> 0.05). Conclusions low serum vitamin D could be involved in reducing HDL-C and increasing HbA1c and thus it may increase cardiovascular risk in subjects with NCCP.
topic Cardiovascular risk
Vitamin D
High density lipoprotein
HbA1c
Non-cardiac chest pain
url http://link.springer.com/article/10.1186/s12944-019-0961-3
work_keys_str_mv AT mohammadjalkhatatbeh associationof25hydroxyvitamindwithhdlcholesterolandothercardiovascularriskbiomarkersinsubjectswithnoncardiacchestpain
AT nooraamara associationof25hydroxyvitamindwithhdlcholesterolandothercardiovascularriskbiomarkersinsubjectswithnoncardiacchestpain
AT khalidkabdulrazzak associationof25hydroxyvitamindwithhdlcholesterolandothercardiovascularriskbiomarkersinsubjectswithnoncardiacchestpain
_version_ 1725090141154836480